Immune responses in patients on TNFi were further enhanced after breakthrough infections as indicated by the induction of T cells reactive to peptides from non-spike SARS-CoV-2 antigens and an increase in polyfunctional spike-specific CD8 T cell responses. Here, CD8A is linked to infection.